ARAMIRA

EUIPO EUIPO 2023 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark ARAMIRA was filed as Word mark on 11/10/2023 at the European Union Intellectual Property Office.
It was registered as a trademark on 04/17/2024. The current status of the mark is "Trademark registered".

Trademark Details Last update: April 19, 2024

Trademark form Word mark
File reference 018949214
Application date November 10, 2023
Publication date January 9, 2024
Entry date April 17, 2024
Expiration date November 10, 2033

Trademark owner

400 Spectrum Center Dr., Suite 2040
92618 Irvine, CA
US

Trademark representatives

45 Mespil Road D04 W2F1 Dublin 4 IE

goods and services

5 Pharmaceutical products, pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing
42 Pharmaceutical research and development; Providing medical and scientific research information in the fields of oncology, autoimmune disorders, immunotherapy, immunotherapeutics, biotechnology, biopharmaceuticals, pharmaceuticals, therapies, diseases, and disorders

ID: 11018949214